MedPath

Comparative study of therapeutic drugs for hyperkalemia in hemodialysis patients

Not Applicable
Conditions
End stage kidney disease hyperkalemia
Registration Number
JPRN-UMIN000052437
Lead Sponsor
Saitama Sekishinkai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients allergic to sodium zirconium cyclosilicate hydrate Patients who are breastfeeding or pregnant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in serum potassium levels before and after switching from cation exchange resin to sodium zirconium cyclosilicate hydrate
Secondary Outcome Measures
NameTimeMethod
Comparison of electrolyte values before and after switching from cation exchange resin to zirconium sodium cyclosilicate hydrate Comparison of bicarbonate concentration before and after switching from cation exchange resin to zirconium sodium cyclosilicate hydrate Comparison of Geriatric Nutritional Risk Index (GNRI) values before and after switching from cation exchange resin to zirconium sodium cyclosilicate hydrate
© Copyright 2025. All Rights Reserved by MedPath